A Pennsylvania judge has ended the latest Risperdal trial before it was able to get to a jury.
Philadelphia Court of Common Pleas Judge Sean Kennedy on Tuesday dismissed the case T.M. v. Janssen Pharmaceuticals on the 11th day of trial. Kennedy’s ruling from the bench, which came a few days into the defense’s case, was based on his determination that the plaintiff’s causation expert’s testimony was inadequate.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
